Interpace BIOSCIENCES, Inc. (IDXG) intrinsic value & 10-year financials
Interpace BIOSCIENCES, Inc. (IDXG) has a Graham intrinsic value of $26.20 per share. At $5.05 on Oct 17, 2026, the stock trades 81% below that value. Over the last 10 fiscal years revenue grew 12.8% a year to $38.7M, with an average return on invested capital of 7.8%.
- Graham intrinsic value
- $26.20
- Share price (Oct 17, 2026)
- $5.05
- Price vs Graham value
- 81% below
- Market cap
- $139.9M
- Revenue (FY2025)
- $38.7M
- Revenue growth (10-yr CAGR)
- 12.8%
- ROIC (10-yr avg)
- 7.8%
- Free cash flow (FY2025)
- $5.5M
IDXG 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $38.7M | $24.6M | $0.89 | $5.5M | 10.5% | 36.5% |
| FY2024 | $46.9M | $6.7M | $0.40 | $3.8M | 17.3% | -30.8% |
| FY2023 | $40.2M | $802.0K | $0.18 | $3.3M | 7.0% | -4.6% |
| FY2022 | $31.8M | -$22.0M | -$5.18 | -$8.0M | -11.4% | 6.5% |
| FY2021 | $41.3M | -$14.9M | — | -$9.1M | -33.9% | 36.6% |
| FY2020 | $32.4M | -$26.5M | — | -$15.6M | -80.5% | 353.2% |
| FY2019 | $24.1M | -$26.7M | — | -$19.1M | -109.7% | -196.7% |
| FY2018 | $21.9M | -$12.2M | — | -$9.1M | -55.3% | -33.3% |
| FY2017 | $15.9M | -$12.2M | — | -$15.3M | -39.6% | -44.1% |
| FY2016 | $13.1M | -$8.3M | — | — | -49.2% | -45.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
INTERPACE BIOSCIENCES, INC. is a consistent compounder, expanding top-line revenue at 12.8% annually over the past decade.
INTERPACE BIOSCIENCES, INC. has historically struggled to out-earn its cost of capital, averaging just -4.9% ROIC.
INTERPACE BIOSCIENCES, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, INTERPACE BIOSCIENCES, INC. is modeled at 12.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $26.20 per share.